Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON34328Not yet recruiting
Open-label, single-arm trial of morphine, vecuronium and propofol, sponsored by Isala. Primary endpoint: Skin conductance peaks per second. Planned start Oct 2010; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON34328.